Cite
HARVARD Citation
Klopp-Schulze, L. et al. (n.d.). 518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia. Open forum infectious diseases. pp. S360-S361. [Online].